Detection of Ehrlichia canis in acutely infected and convalescent dogs is important for effective treatment and control. However, accurate detection has been difficult to achieve, in part because dogs that have been treated therapeutically often remain seropositive for extended periods. A new method, polymerase chain reaction (PCR) assay using biotinylated E. canis-specific primers (PCR-BP), was developed for detection of E. canis. Four dogs experimentally infected with E. canis by intravenous inoculation of whole blood from carrier dogs and 2 naturally infected convalescent carriers were used to compare the specificity and sensitivity of the new method with that of microscopy/blood smear evaluation, serologic test, and conventional PCR assay using E. canis-specific primers. In experimentally infected animals, infection was detected as early as 7 days postexposure using PCR-BP. Although the 2 naturally infected dogs were positive by serologic test and PCR-BP, both were negative by conventional PCR. Results suggest that the new method is a sensitive assay for detection of E. canis infection. In addition, results were obtained more rapidly than with other PCR-based assays.
Ehrlichia species (order Rickettsiales) are obligatory intracellular parasites that produce disease in a variety of vertebrate animals. Most Ehrlichia species are transmitted by ixodid ticks. Ehrlichia canis, the type species of the genus, was first discovered in dogs in Africa and was originally assigned to the genus Rickettsia. 4 Dogs infected with E. canis exhibit fever, anorexia, thrombocytopenia, nonregenerative normocytic/normochromic anemia, leukopenia, petechiae (especially on mucous membranes), and epistaxis. 5, 8 Carrier dogs can serve as a direct source of infection for other dogs through blood transfusion and indirectly via the bite of ticks.
Accurate and rapid methods to detect E. canis infection are needed to identify carrier animals before importation or exportation of pets, and for selection of donor dogs for blood transfusion. Diagnosis of E. canis infections by evaluation of blood smears has always been difficult because of the low parasitemia associated with infection. 8 A serologic test using the indirect fluorescent antibody technique with cell-cultured E. canis as antigen has been developed 12 and used widely. One shortcoming of this test is that antibodies stimulated by Ehrlichia chaffeensis and E. ewingii, closely related species that also infect dogs, both cross-react with E. canis serologically, making differentiation of the individual infections difficult. 2, 3, 13 Experimental studies have demonstrated that dogs remain seropositive to E. canis for many months after spontaneous loss of infection 7 and after treatment with tetracycline. 2 Because dogs often remain seropositive for extended periods, it may be important to reconsider the usefulness of serologic assessment for differentiating true carriers from animals that are cured of ehrlichial infection.
Polymerase chain reaction (PCR) assay has been used suc-cessfully to amplify E. canis DNA from infected dogs during the acute phase of infection. 1, 9 More recently PCR combined with DNA hybridization (PCR-CH) 10 and nested PCR 14 have been used to improve sensitivity over that of the conventional PCR assay. In this study, a PCR assay was developed using biotinylated primers (PCR-BP) for rapid detection of E. canis infections and the efficacy of this assay was compared with that of 3 older methods; blood smear evaluation, serologic test using a commercial assay, a,11 and conventional PCR assay. The DNA was extracted from 200 l of whole blood collected from experimental dogs and 200 l of IDE8 cells infected with E. canis (as a positive control) using either a commercial DNA extraction blood kit or a commercial DNA extraction tissue kit b according to manufacturer's instructions. The DNA was also extracted from a 200-l suspension of DH82 cells infected with E. chaffeensis and from dog platelets infected with Ehrlichia platys. Recovered DNA was used subsequently for conventional PCR assay and for PCR-BP.
Ehrlichia canis-specific primers ECAN5 and ESPEC3 11 were synthesized at the Recombinant DNA and Protein Resource Facility, Oklahoma State University. The PCR assay was done in a 50-l reaction volume containing 5 l of 10ϫ PCR buffer c : 1.25 units of Taq DNA polymerase c ; 20 pM of each primer; 10 l (30 ng/l) of DNA extracted from blood samples; and 0.2 mM of deoxycytidine triphosphate, deoxyadenosine triphosphate, deoxyguanosine triphosphate, and deoxythymidine triphosphate. The DNA extracted from samples positive for E. canis, E. chaffeensis, and E. platys and sterile distilled water (instead of template DNA) were used as controls in the PCR assay. Reactions were carried out in a thermal cycler d using an initial denaturing temperature of 94 C for 3 minutes for 1 cycle followed by denaturing at 94 C for 1 minute, an annealing temperature of 60 C for 1 minute, and an extension temperature of 72 C for 2 minutes. The amplified products were separated on a 1.5% agarose gel using 10 l of the PCR product, stained with ethidium bromide, and visualized using ultraviolet illumination. In the PCR-BP assay, one of the primers (ECAN5) was labeled with biotin; labeling was done at the Recombinant DNA and Protein Resource Facility, Oklahoma State University. The PCR assay conditions were similar to those described above and similar controls were used. The resultant PCR product was purified using a commercial PCR purification system c and 5-10 l of the purified PCR product was blotted onto a nylon membrane manually or by using a commercial dot-blot apparatus. e The membrane was then washed and blocked using a commercial kit. f The labeled PCR product was detected by immunologic reaction using 1:3,000 diluted anti-biotin antibody g conjugated with alkaline phosphatase and the substrates 5-bromo-4-chloro-3-indolyl-phosphate and 4-nitroblue tetrazolium chloride.
Three methods were used to assess the sensitivity of PCR-BP. First, the template E. canis DNA extracted from infected IDE8 cells was diluted to 1:10 (3 ng/l), 1:100 (300 pg/l), 1:1,000 (30 pg/l), 1:10,000 (3 pg/l), and 1:100,000 (300 fg/l) and used (10 l of template per reaction) in the PCR-BP assay. The PCR product was detected using both gel electrophoresis and immunologic methods. Second, PCR product obtained using biotinylated primers was diluted to 800 ng, 160 ng, 32 ng, and 6.4 ng per 10-l concentration and was employed for gel electrophoresis and immunologic detection. Third, DNA extracted from 4 dogs experimentally infected with E. canis and 2 naturally infected dogs was used to test the new method.
For the third testing of the new method, infections were produced in experimental dogs by intravenous inoculation of either 10 ml of whole blood (dogs 3152, 3154, and 3307) from donor dogs that were E. canis carriers or 2 ml of infected IDE8 (50% infected) cells (dog 3325). These 4 dogs were monitored daily by blood smear evaluation and weekly by serologic testing. a Conventional PCR assay using E. canis-specific primers and the new PCR-BP assay were performed on samples from all 4 dogs daily from 1 day before inoculation of infectious blood or culture material until morulae were first observed in peripheral blood smears.
In addition to the experimentally infected dogs, samples (serum and DNA) from 2 naturally infected, privately owned dogs that were also referred to our laboratory for confirmatory diagnosis of E. canis infection were used to test the new method. The serologic test, conventional PCR, and PCR-BP assays were all performed on samples from these 2 naturally infected, convalescent carriers.
Biotinylated primers were very specific in amplifying E. canis DNA; no PCR product was obtained when E. chaffeensis and E. platys DNA were used as template. The PCR-BP assay detected parasite DNA in experimentally infected dogs as early as 7 days after exposure ( Table 1) . As little as 6.4 ng of PCR product was detected by PCR-BP when serially diluted PCR product was tested. The assay performed using diluted template DNA yielded a PCR product that was detectable by gel electrophoresis at 1:100 dilution but not at 1:1,000. However, using immunologic detection, the PCR product was consistently visible at 1:1,000 dilution (sometimes even at 1:10,000 dilution) when 10 l of purified PCR product was blotted onto the membrane (Fig. 1) .
The prepatent periods determined by blood smear evaluation, serologic test, PCR assay, and PCR-BP assay for the experimentally infected dogs are presented in Table 1 . Two naturally infected dogs were positive for E. canis by serologic test. Although E. canis DNA could not be detected when blood was tested by conventional PCR, both dogs were positive when tested with the PCR-BP assay.
The new method detected E. canis infection in experimentally infected animals sooner than did conventional PCR assay, serologic test, or blood smear evaluation. The new method seems to be as sensitive as subinoculation of whole blood into susceptible pups for detection of E. canis parasitemia. Analysis of results of a previous study 6 in which a series of susceptible pups were transfused with whole blood every successive 24 hours after an ''incubating donor'' was exposed to E. canis demonstrated that, beginning at day 7 after exposure, all pups that received blood became infected. The first 6 pups exposed at 24-hour intervals after the incubating carrier was exposed failed to become infected. In the present study, the PCR-BP assay was almost equally sensitive, detecting infection in experimentally exposed pups at 7 days in 1 of 4 dogs and at 8 days in the other 3 dogs.
Although the precise amount of E. canis DNA used in the sensitivity assay was not determined, at least a 10-to 100fold increase in sensitivity in detecting E. canis DNA was found using the PCR-BP assay compared to conventional PCR assay. A previous study 14 showed that nested PCR and PCR-CH are specific and about 100 times more sensitive than conventional PCR assay in detecting E. canis DNA.
Observations of this study demonstrate that the PCR-BP assay is comparable in sensitivity and specificity to nested PCR and PCR-CH.
Based upon this study, PCR-BP assay is an alternative to nested PCR and PCR-CH because the biotin-tagged primer amplifies the PCR signal considerably. The detection step requires only about 1-1.5 hours, making this method faster and, therefore, more cost effective than nested PCR or PCR-CH assays. Another advantage of PCR-BP is that it can be converted to a quantitative assay using densitometry to measure the intensity of the spots on the nylon membrane.
Observations in the present study are consistent with results of an earlier study 10 that used PCR-CH for early (7 days after exposure) detection of parasite DNA in experimentally infected dogs. However, PCR-BP assay did not detect E. canis DNA as early as 4 days, as was demonstrated by others 14 using nested-PCR. In that study, dogs were experimentally exposed to 10 7 infected DH82 cells and the larger infective dose could account for the difference in time of detection. Even though the infective dose in these experiments was not precisely calculated, other studies have shown that shorter prepatent periods (as brief as 10 days determined by blood smear evaluation) are experienced when dogs are exposed to heavily infected cell culture material. In contrast, dogs infected by transfusion of whole blood from carrier animals typically have prepatent periods of 14-20 days (unpublished data). Another explanation for why previous studies 14 detected E. canis DNA earlier by using the nested PCR assay may lie in differences in the amount of whole blood from which DNA was extracted. In the present study, DNA was extracted from 200 l of whole blood, whereas in a previous study 14 DNA was extracted from 200 l of buffy coat (from 4-5 ml of whole blood). Alternatively, nested PCR may, in fact, be a more sensitive technique than is our PCR-BP assay.
The PCR-BP assay has proved useful in detecting E. canis infection in 4 dogs with acute infection and in 2 dogs with latent infections. The technique may prove useful for the detection of other types of ehrlichial infections and for differentiating true carriers from animals that have been treated but remain serologically indistinguishable from infected animals.
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